Author Ziepert, Marita

1 to 10 of 63 Items
  • 2007 Journal Article | 
    ​ ​Dose-escalated CHOEP for the treatment of young patients with aggressive non-Hodgkin's lymphoma: I. A randomized dose escalation and feasibility study with bi- and tri-weekly regimens​
    Trümper, L.; Zwick, C.; Ziepert, M.; Hohloch, K.; Schmits, R.; Mohren, M. & Liersch, R. et al.​ (2007) 
    Annals of Oncology19(3) pp. 538​-544​.​ DOI: https://doi.org/10.1093/annonc/mdm497 
    Details  DOI 
  • 2008 Conference Abstract
    ​ ​Expression of intracellular ABC transporter A3 in aggressive non-Hodgkin lymphoma​
    Chapuy, B. ; Corsham, S.; Klapper, W.; Ziepert, M.; Truemper, L. H. & Wulf, G.​ (2008)
    Annals of Oncology19 pp. 199​-200. ​10th International Conference on Malignant Lymphoma​, Lugano, SWITZERLAND.
    Oxford​: Oxford Univ Press.
    Details  WoS 
  • 2008 Conference Abstract
    ​ ​Response adapted assignment of the number of chemotherapy cycles for the treatment of patients with Diffuse Large B-cell Lymphoma (DLBCL) is not justified: Results of the RICOVER-60 trial of the German high-grade non-hodgkin lymphoma study group (DSHNHL)​
    Schubert, J.; Ziepert, M.; Lengfelder, E.; Mohren, M.; Peter, N.; Reiser, M. & Clemens, M. et al.​ (2008)
    Onkologie31 
    Basel​: Karger.
    Details  WoS 
  • 2008 Conference Abstract
    ​ ​T-cell lymphomas in studies of the German high-grade NHL study group (DSHNHL)​
    Schmitz, N.; Ziepert, M.; Nickelsen, M.; Truemper, L. H.; Glass, B.; Loeffler, M. & Ho, A. D. et al.​ (2008)
    Annals of Oncology19 ​10th International Conference on Malignant Lymphoma​, Lugano, SWITZERLAND.
    Oxford​: Oxford Univ Press.
    Details  WoS 
  • 2008 Journal Article
    ​ ​Prognostic factors for hematotoxicity of chemotherapy in aggressive non-Hodgkin's lymphoma​
    Ziepert, M.; Schmits, R.; Truemper, L. H.; Pfreundschuh, M. & Loeffler, M.​ (2008) 
    Annals of Oncology19(4) pp. 752​-762​.​ DOI: https://doi.org/10.1093/annonc/mdm541 
    Details  DOI  PMID  PMC  WoS 
  • 2008 Journal Article
    ​ ​Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60)​
    Pfreundschuh, M.; Schubert, J.; Ziepert, M.; Schmits, R.; Mohren, M.; Lengfelder, E. & Reiser, M. et al.​ (2008) 
    The Lancet Oncology9(2) pp. 105​-116​.​ DOI: https://doi.org/10.1016/S1470-2045(08)70002-0 
    Details  DOI  PMID  PMC  WoS 
  • 2009 Conference Abstract
    ​ ​Mature T-/NK-cell lymphomas: Prognostic factors and treatment outcome of patients treated on studies of the German High-Grade Lymphoma Study Group (DSHNHL)​
    Schmitz, N.; Ziepert, M.; Nickelsen, M.; Wolf, S. P.; Truemper, L. H.; Loeffler, M. & Ho, A. D. et al.​ (2009)
    Journal of Clinical Oncology27(15) ​45th Annual Meeting of the American-Society-of-Clinical-Oncology​, Orlando, FL.
    Alexandria​: Amer Soc Clinical Oncology.
    Details  PMID  PMC  WoS 
  • 2009 Conference Abstract
    ​ ​Aggressive Chemotherapy (CHOEP-14) and Rituximab or High-Dose Therapy (MegaCHOEP) and Rituximab for Young, High-Risk Patients with Aggressive B-Cell Lymphoma: Results of the MegaCHOEP Trial of the German High - Grade Non-Hodgkin Lymphoma Study Group (DSHNHL)​
    Schmitz, N.; Nickelsen, M.; Ziepert, M.; Haenel, M.; Borchmann, P.; Viardot, A. & Nickenig, C. et al.​ (2009)
    Blood114(22) ​51st Annual Meeting of the American-Society-of-Hematology​, New Orleans, LA.
    Washington​: Amer Soc Hematology.
    Details  WoS 
  • 2009 Conference Abstract
    ​ ​Outcome of Elderly Patients with DLBCL Failing R-CHOP: The Role of Rituximab and High Dose Therapy in Second Line Treatment. A Retrospective Analysis From the RICOVER 60 Trial.​
    Glass, B.; Borgerding, A.; Ziepert, M.; Nickelsen, M.; Loeffler, M.; Pfreundschuh, M. & Truemper, L. H. et al.​ (2009)
    Blood114(22) pp. 1430​-1431. ​51st Annual Meeting of the American-Society-of-Hematology​, New Orleans, LA.
    Washington​: Amer Soc Hematology.
    Details  WoS 
  • 2009 Journal Article | 
    ​ ​Loss of HLA-DR expression and immunoblastic morphology predict adverse outcome in diffuse large B-cell lymphoma - analyses of cases from two prospective randomized clinical trials​
    Bernd, H.-W.; Ziepert, M.; Thorns, C.; Klapper, W.; Wacker, H.-H.; Hummel, M. & Stein, H. et al.​ (2009) 
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL94(11) pp. 1569​-1580​.​ DOI: https://doi.org/10.3324/haematol.2009.008862 
    Details  DOI  PMID  PMC  WoS 

Researcher

Sort

issue date

ASC DESC

Items per Page